Arsanis Stock Price, News & Analysis (NASDAQ:ASNS)

$14.50 +0.01 (+0.07 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$14.49
Today's Range$14.00 - $14.75
52-Week Range$10.40 - $19.73
Volume3,605 shs
Average Volume13,792 shs
Market Capitalization$194.32 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Arsanis (NASDAQ:ASNS)

Arsanis logoArsanis, Inc. is a biopharmaceutical company. The Company is focused on the discovering and developing monoclonal antibodies (mAbs) for the targeted immunotherapy of serious infections. The Company's mAbs focus on specific pathogens and pathogenic processes. Its product pipeline includes ASN100, ASN200, ASN300, ASN400 and ASN500. Its lead program, ASN100, is being studied to prevent hospital-acquired Staphylococcus aureus pneumonia in mechanically ventilated patients heavily colonized with Staphylococcus aureus in their respiratory tracts. Its ASN200 addresses the unmet medical need caused by drug-resistant extra-intestinal escherichia coli infections. Its ASN300 addresses the unmet medical need due to carbapenem-resistant klebsiella pneumoniae infections. Its ASN400 addresses the unmet medical need due to streptococcus pneumoniae, a leading cause of mortality among the elderly. The ASN500 program consisting of potent mAbs targeting respiratory syncytial virus (RSV).

Receive ASNS News and Ratings via Email

Sign-up to receive the latest news and ratings for ASNS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:ASNS
CUSIPN/A
Phone781-819-5704

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees39
Outstanding Shares13,690,000

Arsanis (NASDAQ:ASNS) Frequently Asked Questions

What is Arsanis' stock symbol?

Arsanis trades on the NASDAQ under the ticker symbol "ASNS."

Where is Arsanis' stock going? Where will Arsanis' stock price be in 2018?

4 brokerages have issued 12-month target prices for Arsanis' stock. Their predictions range from $23.00 to $27.00. On average, they expect Arsanis' share price to reach $25.33 in the next year. View Analyst Ratings for Arsanis.

Who are some of Arsanis' key competitors?

Who are Arsanis' key executives?

Arsanis' management team includes the folowing people:

  • Tillman U. Gerngross Ph.D., Co-Founder, Chairman of the Board
  • Rene Russo Pharm.D., President, Chief Executive Officer, Director
  • Eszter Nagy M.D., Ph.D., Co-Founder, Chief Scientific Officer, Director
  • Errik B. Anderson, Co-Founder
  • Michael P. Gray, Chief Financial Officer, Chief Business Officer (Age 45)

When did Arsanis IPO?

(ASNS) raised $50 million in an initial public offering on Thursday, November 16th 2017. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Citigroup, Cowen and Piper Jaffray served as the underwriters for the IPO.

When does Arsanis' lock-up period expire?

Arsanis' lock-up period expires on Tuesday, May 15th. Arsanis had issued 4,000,000 shares in its public offering on November 16th. The total size of the offering was $40,000,000 based on an initial share price of $10.00. After the end of Arsanis' lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Who owns Arsanis stock?

Arsanis' stock is owned by a variety of of retail and institutional investors. Top institutional investors include NEW ENTERPRISE ASSOCIATES 16, L.P. Total Shares: 2,000,000 (14.60%), Sphera Funds Management LTD. (1.97%), Landscape Capital Management L.L.C. (0.29%), Millennium Management LLC (0.17%) and Monashee Investment Management LLC (0.11%). Company insiders that own Arsanis stock include Polaris Venture Management Co and Tillman U Gerngross. View Institutional Ownership Trends for Arsanis.

Who bought Arsanis stock? Who is buying Arsanis stock?

Arsanis' stock was bought by a variety of institutional investors in the last quarter, including Sphera Funds Management LTD., Landscape Capital Management L.L.C., Millennium Management LLC and Monashee Investment Management LLC. Company insiders that have bought Arsanis stock in the last two years include Polaris Venture Management Co and Tillman U Gerngross. View Insider Buying and Selling for Arsanis.

How do I buy Arsanis stock?

Shares of Arsanis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Arsanis' stock price today?

One share of Arsanis stock can currently be purchased for approximately $14.50.

How big of a company is Arsanis?

Arsanis has a market capitalization of $194.32 million. Arsanis employs 39 workers across the globe.

How can I contact Arsanis?

Arsanis' mailing address is 890 WINTER STREET SUITE 230, WALTHAM MA, 02451. The company can be reached via phone at 781-819-5704 or via email at [email protected]


MarketBeat Community Rating for Arsanis (ASNS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  67
MarketBeat's community ratings are surveys of what our community members think about Arsanis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Arsanis (NASDAQ:ASNS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 3.003.00N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $25.33$25.00N/AN/A
Price Target Upside: 105.29% upside78.95% upsideN/AN/A

Arsanis (NASDAQ:ASNS) Consensus Price Target History

Price Target History for Arsanis (NASDAQ:ASNS)

Arsanis (NASDAQ:ASNS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/14/2018Cantor FitzgeraldInitiated CoverageOverweight$26.00MediumView Rating Details
12/11/2017CitigroupInitiated CoverageBuy -> Buy$27.00HighView Rating Details
12/11/2017CowenInitiated CoverageOutperformHighView Rating Details
12/11/2017Piper Jaffray CompaniesInitiated CoverageOverweight -> Overweight$23.00HighView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Earnings History for Arsanis (NASDAQ:ASNS)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Arsanis (NASDAQ:ASNS) Earnings Estimates

Current Year EPS Consensus Estimate: $-15.08 EPS
Next Year EPS Consensus Estimate: $-10.57 EPS

Dividends

Dividend History for Arsanis (NASDAQ:ASNS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Arsanis (NASDAQ ASNS) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 43.64%
Insider Trades by Quarter for Arsanis (NASDAQ:ASNS)
Institutional Ownership by Quarter for Arsanis (NASDAQ:ASNS)

Arsanis (NASDAQ ASNS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/20/2017Polaris Venture Management Co.Major ShareholderBuy500,000$10.00$5,000,000.00View SEC Filing  
11/20/2017Tillman U GerngrossDirectorBuy200,000$10.00$2,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Arsanis (NASDAQ ASNS) News Headlines

Source:
DateHeadline
Zacks: Arsanis Inc (ASNS) Receives Consensus Rating of "Strong Buy" from AnalystsZacks: Arsanis Inc (ASNS) Receives Consensus Rating of "Strong Buy" from Analysts
www.americanbankingnews.com - February 21 at 9:36 PM
Zacks: Analysts Expect Arsanis Inc (ASNS) Will Announce Earnings of -$3.05 Per ShareZacks: Analysts Expect Arsanis Inc (ASNS) Will Announce Earnings of -$3.05 Per Share
www.americanbankingnews.com - February 19 at 1:16 PM
Analysts Offer Predictions for Arsanis Incs FY2017 Earnings (ASNS)Analysts Offer Predictions for Arsanis Inc's FY2017 Earnings (ASNS)
www.americanbankingnews.com - February 19 at 1:08 AM
 Arsanis Inc (ASNS) Receives Consensus Rating of "Strong Buy" from Analysts Arsanis Inc (ASNS) Receives Consensus Rating of "Strong Buy" from Analysts
www.americanbankingnews.com - February 18 at 7:40 PM
Arsanis (ASNS) Research Coverage Started at Cantor FitzgeraldArsanis (ASNS) Research Coverage Started at Cantor Fitzgerald
www.americanbankingnews.com - February 14 at 7:12 PM
 Arsanis Inc (ASNS) Given Average Rating of "Strong Buy" by Analysts Arsanis Inc (ASNS) Given Average Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - February 2 at 7:22 PM
What You Must Know About Arsanis Inc’s (NASDAQ:ASNS) ROEWhat You Must Know About Arsanis Inc’s (NASDAQ:ASNS) ROE
finance.yahoo.com - December 29 at 6:16 PM
Arsanis, Inc.s Quiet Period Will Expire  on December 26th (NASDAQ:ASNS)Arsanis, Inc.'s Quiet Period Will Expire on December 26th (NASDAQ:ASNS)
www.americanbankingnews.com - December 19 at 1:14 AM
Arsanis (ASNS) Coverage Initiated by Analysts at Piper Jaffray CompaniesArsanis (ASNS) Coverage Initiated by Analysts at Piper Jaffray Companies
www.americanbankingnews.com - December 11 at 9:26 PM
Arsanis (ASNS) Now Covered by Analysts at CitigroupArsanis (ASNS) Now Covered by Analysts at Citigroup
www.americanbankingnews.com - December 11 at 12:34 PM
Arsanis (ASNS) Earns Outperform Rating from Analysts at CowenArsanis (ASNS) Earns Outperform Rating from Analysts at Cowen
www.americanbankingnews.com - December 11 at 8:22 AM
Arsanis Announces Pricing of Initial Public OfferingArsanis Announces Pricing of Initial Public Offering
globenewswire.com - November 29 at 8:04 AM
Biotech Arsanis prices IPO at $10, below $15 to $17 price rangeBiotech Arsanis prices IPO at $10, below $15 to $17 price range
finance.yahoo.com - November 23 at 8:44 AM
Arsanis Announces Closing of Initial Public OfferingArsanis Announces Closing of Initial Public Offering
finance.yahoo.com - November 23 at 8:44 AM
Tillman U. Gerngross Acquires 200,000 Shares of Arsanis, Inc. (ASNS) StockTillman U. Gerngross Acquires 200,000 Shares of Arsanis, Inc. (ASNS) Stock
www.americanbankingnews.com - November 20 at 7:36 PM
Polaris Venture Management Co. Acquires 500,000 Shares of Arsanis, Inc. (ASNS) StockPolaris Venture Management Co. Acquires 500,000 Shares of Arsanis, Inc. (ASNS) Stock
www.americanbankingnews.com - November 20 at 7:36 PM
Arsanis (ASNS) to Raise $50 Million in IPOArsanis (ASNS) to Raise $50 Million in IPO
www.americanbankingnews.com - November 8 at 1:26 AM

SEC Filings

Arsanis (NASDAQ:ASNS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Arsanis (NASDAQ:ASNS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Arsanis (NASDAQ ASNS) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.